Suppr超能文献

血小板活化因子受体拮抗剂不影响被动型海曼肾炎的发展。

Receptor antagonists of platelet-activating factor do not influence the development of passive Heymann nephritis.

作者信息

Salvidio G, Brentjens J, Camussi G

机构信息

Cattedra di Nefrologia, Istituto Scientifico di Medicina Interna, Università di Genova, Italy.

出版信息

J Lipid Mediat. 1991 Mar-Apr;3(2):197-204.

PMID:1665716
Abstract

Heymann nephritis in the rat is a proteinuric condition caused by glomerular lesions similar to those found in human membranous nephritis. In the present study the effect of two different receptor antagonists of platelet-activating factor (PAF) on the course of passive Heymann nephritis was assessed. It was found that rats treated with either antagonist showed the same degree of proteinuria and the same glomerular immunopathological features as untreated rats. Furthermore, at sacrifice, 7 days after the initiation of the disease, the concentration of circulating PAF in treated as well as untreated rats was normal. These results indicate that PAF is not crucial in the pathogenesis of Heymann nephritis.

摘要

大鼠的海曼肾炎是一种蛋白尿病症,由与人类膜性肾病中发现的类似的肾小球病变引起。在本研究中,评估了两种不同的血小板活化因子(PAF)受体拮抗剂对被动性海曼肾炎病程的影响。结果发现,用任何一种拮抗剂治疗的大鼠与未治疗的大鼠表现出相同程度的蛋白尿和相同的肾小球免疫病理特征。此外,在疾病开始7天后处死时,治疗组和未治疗组大鼠循环PAF的浓度均正常。这些结果表明,PAF在海曼肾炎的发病机制中并非至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验